Continuous response of certolizumab pegol in the treatment of patients with plaque-psoriasis: results from the two multicenter, randomized, placebo-controlled Phase-3-Studies (CIMPASI-1 and CIMPASI-2)

Authors

Kristian Reich
Alice B. Gottlieb, New York Medical CollegeFollow

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

2018

Journal Title

Journal Der Deutschen Dermatologischen Gesellschaft

Department

Dermatology

Comments

Please see the work itself for a complete list of authors

Recommended Citation

Reich, K., & Gottlieb, A. B. (2018). Continuous response of certolizumab pegol in the treatment of patients with plaque-psoriasis: results from the two multicenter, randomized, placebo-controlled Phase-3-Studies (CIMPASI-1 and CIMPASI-2). Journal Der Deutschen Dermatologischen Gesellschaft, 16 (Suppl. 1), 14-15. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/350